Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

WALGREENS BOOTS ALLIANCE, INC.

(WBA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Walgreens Starts Offering Moderna, Johnson & Johnson COVID-19 Booster Shots

10/22/2021 | 10:06am EST


ę MT Newswires 2021
All news about WALGREENS BOOTS ALLIANCE, INC.
12/03Walgreens Explores Options for British Retail Chain Boots
CI
12/03NORTH AMERICAN MORNING BRIEFING : Oil Rises, Stock Futures Waver as Markets Cap Volatile W..
DJ
12/02U.S. OMICRON PLAN : boosters, free at-home tests, tighter travel rules
RE
12/02MarketScreener's World Press Review - December 2, 2021
11/30Walgreens to Buy Remaining Shares in GEHE-Alliance Healthcare JV from McKesson for Undi..
MT
11/30Walgreens Boots Alliance Acquires Remaining Stake in German GEHE-Alliance Healthcare Jo..
BU
11/26WALGREENS BOOTS ALLIANCE, INC. : Entry into a Material Definitive Agreement, Financial Sta..
AQ
11/24MarketScreener's World Press Review - November 24, 2021
11/23Elizabeth Holmes denies deception at her criminal trial
AQ
11/23Federal Jury Finds CVS, Walmart, Walgreens Contributed to Opioid Crisis in Two Ohio Cou..
MT
More news
Analyst Recommendations on WALGREENS BOOTS ALLIANCE, INC.
More recommendations
Financials (USD)
Sales 2022 131 B - -
Net income 2022 3 315 M - -
Net Debt 2022 11 277 M - -
P/E ratio 2022 12,3x
Yield 2022 4,17%
Capitalization 40 277 M 40 277 M -
EV / Sales 2022 0,39x
EV / Sales 2023 0,36x
Nbr of Employees 258 500
Free-Float 61,1%
Chart WALGREENS BOOTS ALLIANCE, INC.
Duration : Period :
Walgreens Boots Alliance, Inc. Technical Analysis Chart | WBA | US9314271084 | MarketScreener
Technical analysis trends WALGREENS BOOTS ALLIANCE, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Last Close Price 46,53 $
Average target price 53,86 $
Spread / Average Target 15,8%
EPS Revisions
Managers and Directors
Rosalind Gates Brewer Chief Executive Officer & Director
John Standley President & Executive Vice President
James Kehoe Global Chief Financial Officer & Executive VP
Stefano Pessina Executive Chairman
Francesco Tinto Global Chief Information Officer & Senior VP
Sector and Competitors